Evidence map›Paper›PMID 29416334›Full record

ArticleInternational journal of nanomedicine2018

Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells.

Yinxing Shen, Junqi Zhang, Weiju Hao, Tong Wang, Jing Liu, Youhua Xie, Shouhong Xu, Honglai Liu

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Nanotechnology-Assisted Cell Tracking.Nanomaterials (Basel, Switzerland) · 2022
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yinxing Shen *State Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology.
Junqi Zhang *Department of Medical Microbiology and Parasitology, Key Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.
Weiju HaoState Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology.
Tong WangState Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology.
Jing LiuDepartment of Medical Microbiology and Parasitology, Key Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.
Youhua XieDepartment of Medical Microbiology and Parasitology, Key Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of China.
Shouhong XuState Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology.
Honglai LiuState Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology.
East China University of Science and Technology · CNShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efficient delivery of nucleic acids into target cells is crucial for nucleic acid-based therapies. Various nucleic acid delivery systems have been developed, each with its own advantages and limitations. We previously developed a nanoparticle-based delivery system for small chemical drugs using pH-responsive PEG

Indexed as

MicellesAptamers, NucleotideBreast NeoplasmsCell CountCell DeathCell Line, TumorCell SurvivalDrug CarriersErb-b2 Receptor Tyrosine KinasesFemaleHumansHydrogen-Ion ConcentrationLysosomesNanoparticlesProteolysisAptamers, NucleotideDrug CarriersERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesMicellesHER2-targeted therapynucleic acid deliverypH-responsive micelle-like nanoparticles

Identifiers

PMID29416334
PMCPMC5790103
OpenAlexW2789050551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.